Eastman Chemical Company EMN
66.97
0.78
1.18%
as of 25 Sep
- Market cap
- $7.6B
- P/E
- 17.3×
Follow EMN
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
12.08% | 7.97% | 6.63% | 7.32% | |
| 4.65% | 3.15% | 2.64% | 2.88% | ||
ROIC |
6.46% | 5.01% | 4.19% | 4.72% | |
Return on Tangible Assets |
9.48% | 7.05% | 5.72% | 6.22% | |
Average Days of Receivables |
51.53 | 41.66 | 51.42 | 56.20 | |
Free Cash Flow per Share |
3.45 | 3.70 | 4.36 | 4.72 | |
Free Cash Flow |
395.00 | 424.00 | 498.00 | 539.00 | |
Capital Expenditures |
(613.00) | (546.00) | (502.00) | (452.00) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
9.07% | 8.98% | 8.93% | 8.76% | |
Accounts Receivable Turnover |
6.93 | 8.06 | 6.98 | 6.55 | |
Accounts Payable Turnover |
3.48 | 3.20 | 3.48 | 3.45 | |
Inventory Turnover |
3.63 | 3.48 | 3.31 | 3.34 | |
Average Days of Payables |
97.80 | 109.16 | 105.22 | 106.63 | |
Days of Inventory on Hand |
101.52 | 104.62 | 109.43 | 107.96 | |
Tax Rate |
(0.18) | (0.16) | (0.12) | (0.18) | |
Research and Development Expense of Revenue |
2.91% | 2.91% | 2.87% | 2.77% | |
Selling, General and Administrative Expense of Revenue |
7.55% | 7.52% | 7.57% | 7.69% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.44 | 2.05 | 2.51 | 2.24 | |
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Capex/Depreciation |
(1.20) | (1.06) | (0.97) | (0.86) | |
Revenue per Share |
78.88 | 76.30 | 75.65 | 77.56 | |
Operating CF per Share |
8.81 | 8.46 | 8.76 | 8.67 | |
Capex per Share |
(5.36) | (4.76) | (4.40) | (3.95) | |
Capex to Sales |
0.07 | 0.06 | 0.06 | 0.05 | |
Net Profit Margin |
7.75% | 5.42% | 4.62% | 4.99% |
Columns are period end dates